|
× |
 |
Pimavanserin: A 2019 Clarification on the FDA Update PDF |
$40.00 |
|
$40.00 |
|
× |
|
A Randomized, Placebo-Controlled Trial of N-Acetylcysteine Plus Imaginal Desensitization for Nicotine-Dependent Pathological Gamblers PDF |
$40.00 |
|
$40.00 |
|
× |
|
Complementary and Alternative Medicine for Major Depressive Disorder: A Meta-Analysis of Patient Characteristics, Placebo-Response Rates, and Treatment Outcomes Relative to Standard Antidepressants PDF |
$40.00 |
|
$40.00 |
|
× |
|
Natural and Synthetic Cannabinoids for Agitation and Aggression in Alzheimer's Disease: A Meta-Analysis PDF |
$40.00 |
|
$40.00 |
|
× |
|
Efficacy and Tolerability of Once-Daily Extended Release Quetiapine Fumarate in Acute Schizophrenia: A Randomized, Double-Blind, Placebo-Controlled Study PDF |
$40.00 |
|
$40.00 |
|
× |
|
Sexual Functioning Assessed in 4 Double-Blind Placebo- and Paroxetine-Controlled Trials of Duloxetine for Major Depressive Disorder PDF |
$40.00 |
|
$40.00 |
|
× |
|
Longitudinal Examination of the Skeletal Effects of Selective Serotonin Reuptake Inhibitors and Risperidone in Boys PDF |
$40.00 |
|
$40.00 |
|
× |
|
Reducing Anticholinergic Medication Burden in Patients With Psychotic or Bipolar Disorders PDF |
$40.00 |
|
$40.00 |
|
|
